Background: The first-line treatment for patients with advanced prostate cancer (PC) is androgen deprivation therapy. This therapy is initially effective, but after some time tumors relapse, predominantly within the bone, and are then termed castration-resistant prostate cancer (CRPC). The majority of CRPC tumors show androgen receptor (AR) activity despite castrate levels of circulating testosterone. AR activity could be caused by several mechanisms including; intratumoral androgen synthesis, AR amplification, AR mutations and expression of AR splice variants. The mechanisms controlling CRPC growth in the clinically most relevant metastatic site, the bone, are not fully identified. The purpose of this thesis was therefore to explore AR expression and possible mechanisms behind CRPC growth in PC bone metastases in order to find mechanisms that could be targeted for treatment and/or predict response to certain therapies. Materials and Methods: We have examined hormone-naïve and CRPC bone metastases samples obtained from patients at metastasis surgery, non-malignant and malignant prostate samples obtained from patients at radical prostatectomy, and PC cell lines cultured in vitro. Analysis has been performed using RT-PCR, whole-genome expression arrays, immunohistochemistry, western blotting, FISH, copy number assays and gene ontology analysis. Functional studies have been made by protein overexpression and knock-down in PC cells in vitro and effects studied by evaluation of cell viability, migration, and invasion. Results: We found that high nuclear AR immunostaining (presumed to reflect high AR activity) in bone metastases from CRPC patients was associated with a particularly poor prognosis, while no difference in AR staining was observed between hormone-naïve and CRPC metastases. Further, expression of AR splice variants (AR-V7, AR-V567es) was associated with a high nuclear AR immunostaining score and shown to be increased in CRPC compared to hormone-naïve bone metastases. High levels (levels in the upper quartile) of AR splice variants in CRPC bone metastases was related to disturbed cell cycle regulation and short patients survival. No differences in steroidogenic enzyme levels were detected between CRPC and hormone-naïve bone metastases. Higher levels of enzymes involved in late steps of androgen synthesis (adrenal gland steroid conversion) were observed in bone metastases than in non-malignant and/or malignant prostate tissue, while the enzyme levels in earlier steps (de novo steroidogenesis) were lower in bone metastases. A subgroup of metastases expressed very high levels of AKR1C3, indicating that this group may have an induced capacity of converting adrenal-gland derived steroids into more potent androgens. This was not associated to CRPC but merely with the advanced stage of metastasis. High protein levels of AR splice variants were found in bone metastases with low AKR1C3 levels, while metastases with high AKR1C3 levels primarily contained low AR variant levels. Furthermore, about half of the CRPC bone metastases showed androgen receptor gene amplification which was associated with co-amplification of YIPF6, and a gene expression pattern that pointed at decreased osteoclast activity, and consequently decreased bone resorption. Conclusions: The majority of CRPC bone metastases show high nuclear AR immunostaining that seems to be associated with a particularly unfavorable outcome after metastasis surgery. Subgroups of CRPC bone metastases could be identified according to presence of AR amplification and expression levels of AKR1C3 or AR splice variants, which might have clinical relevance for treatment of PC patients. / <p>Författaren är även publicerad med efternamnet Hörnberg.</p>

Στόχος: Ο υποδοχέας του γλουταμινικού οξέος ΝMDA (N-methyl-D-aspartate), αποτελεί μόριο-κλειδί που διαμεσολαβεί πολλούς τύπους συναπτικής πλαστικότητας στο κεντρικό νευρικό σύστημα. Στο οπτικό σύστημα η πλαστικότητα ξεκινά στο επίπεδο του αμφιβληστοειδούς χιτώνα. Κατά την ανάπτυξη του αμφιβληστροειδούς οι υποδοχείς NMDA συμμετέχουν σε φαινόμενα πλαστικότητας εξαρτώμενα από την εμπειρία όπως ο λειτουργικός διαχωρισμός των ON και OFF μονοπατιών. Η ανάπτυξη και η οπτική αποστέρηση επηρεάζουν επίσης τις ηλεκτροφυσιολογικές ιδιότητες των υποδοχέων NMDA στον αμφιβληστροειδή του επίμυος καθώς και την έκφραση των υπομονάδων του NR1 και NR2. Η βασική υπομονάδα NR1 υφίσταται εναλλακτικό μάτισμα με αποτέλεσμα να εμφανίζεται σε οκτώ διαφορετικές ισομορφές που προσδίδουν μοριακή ποικιλότητα στον υποδοχέα. Το ερώτημα που ετέθη ήταν εάν η έκφραση των ισομορφών της υπομονάδας NR1 ρυθμίζεται κατά την ανάπτυξη του αμφιβληστροειδούς χιτώνα του επίμυος και εάν μεταβάλλεται από την οπτική εμπειρία. Μέθοδος: Χρησιμοποιήθηκαν αμφιβληστροειδείς επίμυων (Wistar) που μεγάλωσαν είτε σε φυσιολογικό ημερήσιο κύκλο 12 ώρες φως/12 ώρες σκοτάδι [normal-reared (NR)], είτε σε διαρκές σκοτάδι [dark-reared (DR)] από την 9η έως την 60η ημέρα μετά τη γέννηση. Η μελέτη της έκφρασης των ισομορφών του αμινοτελικού (NR1a, NR1b) και του καρβοξυτελικού (NR1-1, NR1-2, NR1-3, NR1-4) άκρου της υπομονάδας NR1 έγινε με τη μέθοδο της real-time PCR. Αποτελέσματα: Το αναπτυξιακό προφίλ όλων των ισομορφών εμφάνισε διαφορετική αύξηση κατά τη διάρκεια της δεύτερης και τρίτης εβδομάδας, με μέγιστη έκφραση στο τέλος της τρίτης εβδομάδας. Μεταξύ των ισομορφών του αμινοτελικού άκρου, η NR1b εκφραζόταν σταθερά σε υψηλότερα επίπεδα σε σχέση με την NR1a, ενώ μεταξύ των ισομορφών του καρβοξυτελικού άκρου, η NR1-2 εκφραζόταν σε υψηλότερα επίπεδα από την NR1-4, ενώ τόσο η NR1-1 όσο και η NR1-3 εκφράζονταν σε χαμηλά επίπεδα. Η ανάπτυξη στο σκοτάδι μείωσε την έκφραση όλων των ισομορφών σε πολλά αναπτυξιακά στάδια και στο ενήλικο ζώο. Σημαντική αλληλεπίδραση μεταξύ ηλικίας και οπτικής εμπειρίας προέκυψε για τις ισομορφές NR1a, NR1-2 και NR1-4. Συμπεράσματα: Η έκφραση όλων των ισομορφών της υπομονάδας NR1 μεταβάλλεται κατά την ανάπτυξη του αμφιβληστροειδούς του επίμυος, ενώ ορισμένες (NR1a, NR1-2 and NR1-4) ρυθμίζονται τόσο από την ηλικία όσο και από την οπτική εμπειρία. Τέτοιες μεταβολές μπορεί να παίζουν σημαντικό ρόλο σε φαινόμενα πλαστικότητας που λαμβάνουν χώρα στον αμφιβληστροειδή χιτώνα. / Purpose: The N-methyl-D-aspartate (NMDA) type of glutamate ionotropic receptor is a key molecule mediating plasticity related processes in the central nervous system. Visual system plasticity begins in the retina. During postnatal retinal development NMDA receptor has been shown to be involved in experience dependent plasticity such as the functional segregation of ON and OFF pathways. Development and visual deprivation have been found to affect the kinetics of NMDA receptor in rat retina and the expression of its main subunits NR1 and NR2. The NR1 fundamental subunit of NMDA receptor exists in eight distinct splice isoforms. Knowing that alternative splicing of the NR1 subunit offers a further molecular diversity to the receptor, we have addressed the question of whether the alternative splicing of NR1 subunit of the NMDA receptor is regulated during postnatal retinal development and whether this regulation is altered by visual experience. Methods: Retinas were dissected from eyes of Wistar rats raised either in normal 12-hour light/12-hour dark cycle [normal-reared (NR)], or in complete darkness [dark-reared (DR)] at postnatal days 9 to 60. Real-time PCR was performed in order to assess the mRNA expression of NR1 isoforms using oligonucleotide primers specific for N- terminal (NR1a, NR1b) and C-terminal splice variants (NR1-1, NR1-2, NR1-3, NR1-4). Results: The developmental profiles of mRNA expression levels of both N- and C-terminal NR1 isoforms showed differential increases during the second and third postnatal weeks, while their expression peaked at the end of the third week. Among N-terminal isoforms NR1b was constantly expressed at higher levels compared to NR1a and among the C-terminal isoforms, NR1-2 was expressed at higher levels than NR1-4, while both NR1-1 and NR1-3 were expressed at low levels. Dark-rearing led to reductions in both N- and C-terminal NR1 variants in several developmental ages and in adult retina. A significant age and experience interaction was observed at NR1a N-terminal isoform, and at the most abundant C-terminal isoforms NR1-2 and NR1-4. Conclusions: Our results have demonstrated that all NR1 splice isoforms are developmentally regulated in rat retina and some of them (NR1a, NR1-2 and NR1-4) are also bidirectionally regulated by age and visual experience. Such changes may play an important role in the plastic and activity-dependent events taking place in retina.

BAI2 gehört zu den Adhesion-G-Protein-gekoppelten Rezeptoren (aGPCR). Diese bisher wenig untersuchte Klasse von ca. 30 GPCR ist charakterisiert durch eine komplexe genomische Struktur, sehr große extrazelluläre Domänen und eine Vielzahl von Splicevarianten. Bisher ist bei den meisten aGPCR, wie auch bei BAI2, wenig über ihre Signaltransduktion und Funktion bekannt. Zum Verständnis der physiologischen Relevanz und zur Suche nach dem endogenen Agonist sind Kenntnisse über Proteinstruktur, Splicevarianten und Signaltransduktion essentiell. Ziel dieser Arbeit war es, mittels verschiedener in vitro-Methoden die Proteinstruktur des BAI2 in den transmembranären und intrazellulären Domänen näher zu untersuchen, sowie die natürlichen Splicevarianten in diesem Bereich, deren evolutionäre Konservierung, Gewebespezifität und Quantität zu erfassen. Für beide gefundenen Splicevarianten, eine im dritten intrazellulären Loop (ICL3) und eine im C-Terminus, konnte eine evolutionäre Konservierung auf Aminosäure- und genomischer Organisationsebene, sowie ihre Entstehung durch Exonskipping nachgewiesen werden. Nachfolgend wurden die Splicevarianten auf mögliche Interaktionen mit intrazellulären Komponenten untersucht. In dieser Arbeit konnte gezeigt werden, dass beide ICL3-Splicevarianten natürlicherweise in einem definierten Verhältnis auftreten. Außerdem konnte gezeigt werden, dass die lange ICL3-Variante des BAI2 nicht zu einer Änderung der Membrantopologie des Rezeptors, einer Homodimerisierung über die zusätzliche Aminosäuresequenz oder zu einer Interaktion mit dem C-Terminus führt. Die Splicevariante im humanen C-Terminus des BAI2 konnte als eine variable, durch Exonskipping entstandene Calcium-unabhängige Calmodulin-Bindungsstelle identifiziert werden. Diese Arbeit belegt die Existenz mehrerer BAI2-Isoformen in vivo. Die Struktur dieser Isoformen lässt unterschiedliche Funktionalitäten vermuten. Auch wenn erste Untersuchungen zwischen den beiden ICL3-Varianten keinen Unterschied ergaben, sind diese Erkenntnisse für die weitere Analyse der Signaltransduktion und Ligandensuche bedeutend. Es ist z.B. denkbar, dass sich die beiden ICL3-Varianten in der G-Protein-Kopplung oder bei der Rekrutierung von intrazellulären Interaktionspartnern unterscheiden oder dass die Splicevariante im C-Terminus zu einer Scaffold- Funktion des Calmodulins führt und/oder die Signaltransduktion durch eine permanente Bindung des Calmodulins an einer Isoform moduliert wird.

Master of Science / Department of Animal Sciences and Industry / Timothy G. Rozell / Several alternatively-spliced mRNA transcripts of the follicle stimulating hormone receptor (FSHR) have been identified in sheep, including FSHR-1 (G protein-coupled form), FSHR-2 (dominant negative form), and FSHR-3 (growth factor type-1 form). Coupling of the FSHR to signaling pathways which activate different downstream effectors leads to speculation that specific splice variants may be transcribed under differing physiological conditions. This is the first study to correlate expression patterns of FSHR-1, FSHR-2, and FSHR-3 and development of follicles in the mature sheep ovary. In Experiment 1, 8 Suffolk-cross ewes were allowed to come into estrus naturally and were euthanized 24 (n=3), 36 (n=3), and 48 (n=2) hours after the onset of estrus. In Experiment 2, 7 Suffolk-cross ewes received CIDRs for 14 days. At CIDR removal, PMSG (500IU) was administered to treatment ewes (n=3), while controls (n=4) received no PMSG. Ewes were euthanized 24 (n=4; 2 CIDR only, 2 PMSG) or 36 (n=3; 2 CIDR only, 1 PMSG) hours later. All visible follicles were aspirated and pooled according to follicular diameter: small (≤ 2.0 mm), medium (2.1-4.0 mm), large (4.1-6.0 mm), and preovulatory (≥ 6.1 mm). Granulosa cells were separated from follicular fluid by centrifugation. Total RNA was extracted from granulosa cells (GC) and reversed transcribed. The resulting cDNA was subjected to qPCR, using primer sets designed to amplify each variant specifically. For Experiment 1, regardless of time after onset of estrus, relative expression of FSHR-3 exceeded that of both FSHR-1 and FSHR-2 in medium follicles (p < 0.01), and tended to be higher in small follicles (p=0.09). For Experiment 2, treatment with PMSG did not significantly alter expression patterns of FSHR variants (p=0.18). The FSHR-3 was expressed higher than FSHR-2 in all follicle sizes (p < 0.01) and was numerically more highly expressed than FSHR-1, although this difference was not significant (p > 0.11). These experiments show that in addition to the well characterized G protein-coupled form of the FSHR, alternatively spliced variants of the FSHR may participate in follicular dynamics during the first follicular wave of the sheep estrous cycle. Furthermore, these results would indicate that an “alternatively” spliced form of the FSHR (FSHR-3) is the predominant form of the FSHR in the sheep.

No description available.

No description available.

Indiana University-Purdue University Indianapolis (IUPUI) / Carboxylesterases (CES) are enzymes that metabolize a wide variety of compounds including esters, thioesters, carbamates, and amides. In humans there are three known carboxylesterase genes CES1, CES2, and CES3. Irinotecan (CPT-11) and capecitabine are important chemotherapeutic prodrugs that are used for the treatment of colorectal cancer. Of the three CES isoenzymes, CES2 has the highest catalytic efficiency for irinotecan activation. There is large inter-individual variation in response to treatment with irinotecan. Life-threatening late-onset diarrhea has been reported in approximately 13% of patients receiving irinotecan. Several studies have reported single nucleotide polymorphisms (SNPs) for the CES2 gene. However, there has been no consensus on the effect of different CES2 SNPs and their relationship to CES2 RNA expression or irinotecan hydrolase activity. Three CES2 mRNA transcripts of approximately 2kb,3kb, and 4kb have been identified by multi-tissue northern analysis. The expressed sequence tag (EST) database indicates that CES2 undergoes several splicing events that could generate up to six potential proteins. Four of the proteins CES2, CES2458-473, CES2+64, CES21-93 were studied to characterize their expression and activity. Multi-tissue northern analysis revealed that CES2+64 corresponds to the 4kb and 3kb transcripts while CES21-93 is located only in the 4 kb transcript. CES2458-473 is an inactive splice variant that accounts for approximately 6% of the CES2 transcripts in normal and tumor colon tissue. There is large inter-individual variation in CES2 expression in both tumor and normal colon samples. Characterization of CES2+64 identified the protein as normal CES2 indicating that the signal peptide is recognized in spite of the additional 64 amino acids at the N-terminus. Sub-cellular localization studies revealed that CES2 and CES2+64 localize to the ER, and CES21-93 localizes to the cytoplasm. To date CES2 SNP data has not provided any explanation for the high inter-individual variability in response to irinotecan treatment. Multi-tissue northern blots indicate that CES2 is expressed in a tissue specific manner. We have identified the CES2 variants which correspond to each mRNA transcript. This information will be critical to defining the role of CES2 variants in the different tissues.

No description available.